GSK, Avalon sign drug-discovery startup alliance

04/23/2013 | Reuters

GlaxoSmithKline teamed up with venture capital firm Avalon Ventures to provide funding to up to 10 drug-discovery startup firms that will be established by Avalon within three years. GSK will contribute up to $465 million while Avalon will provide as much as $30 million. GSK will have an option to purchase each startup.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
Washington DC, DC